Stockscreener 앱 받기
12.06
0.00%
0.00
시간 외 거래:
12.05
-0.010
-0.08%
전일 마감가:
$12.06
열려 있는:
$12.1
하루 거래량:
359.67K
Relative Volume:
0.68
시가총액:
$658.03M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.01%
1개월 성능:
+6.16%
6개월 성능:
-18.95%
1년 성능:
+0.00%
1일 변동 폭
$11.70
$12.33
1주일 범위
$11.47
$12.33
52주 변동 폭
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
명칭
Bicara Therapeutics Inc
전화
617-468-4219
주소
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
12.06 | 658.03M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-05-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 개시 | Wells Fargo | Underweight |
| 2025-02-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-08 | 개시 | TD Cowen | Buy |
모두보기
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
Nuveen LLC Takes Position in Bicara Therapeutics Inc. $BCAX - Defense World
Can Bicara Therapeutics Inc. outperform under higher oil pricesTrade Risk Summary & Growth Focused Investment Plans - خودرو بانک
Bicara Therapeutics Inc. stock prediction for this weekDay Trade & Capital Protection Trade Alerts - Newser
What recovery options are there for Bicara Therapeutics Inc.2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Should I invest in Bicara Therapeutics Inc. before earnings2025 Growth vs Value & Fast Entry Momentum Alerts - خودرو بانک
Is Bicara Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Drop Watch & Daily Price Action Insights - خودرو بانک
Bicara Therapeutics Inc. stock momentum explainedQuarterly Risk Review & High Win Rate Trade Alerts - Newser
How to track smart money flows in Bicara Therapeutics Inc.Share Buyback & Daily Volume Surge Trade Alerts - Newser
A | Will Bicara Therapeutics Inc. outperform tech stocksEarnings Summary Report & Safe Entry Zone Tips - خودرو بانک
Applying Elliott Wave Theory to Bicara Therapeutics Inc.July 2025 Update & Safe Capital Allocation Plans - Newser
Regression analysis insights on Bicara Therapeutics Inc. performanceWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Can Bicara Therapeutics Inc. sustain earnings growthWeekly Stock Analysis & Expert Curated Trade Setup Alerts - خودرو بانک
Bicara Therapeutics: A Promising Yet Niche Player in the HNSCC Market - AInvest
Bicara Therapeutics: Promising, But Only For The Patient (NASDAQ:BCAX) - Seeking Alpha
Technical signs of recovery in Bicara Therapeutics Inc.Quarterly Portfolio Report & Low Risk Investment Opportunities - Newser
Will breakout in Bicara Therapeutics Inc. lead to full recoveryMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Bicara Therapeutics Inc. see short term momentumWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
What to expect from Bicara Therapeutics Inc. in the next 30 daysWeekly Loss Report & Weekly High Return Forecasts - Newser
Is Bicara Therapeutics Inc. being accumulated by smart moneyJuly 2025 Review & Risk Managed Trade Strategies - خودرو بانک
Ranking Bicara Therapeutics Inc. among high performing stocks via toolsBuy Signal & Risk Controlled Stock Alerts - Newser
Bicara Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Expert Approved Trade Ideas - Newser
How moving averages guide Bicara Therapeutics Inc. tradingPortfolio Risk Summary & Real-Time Market Trend Scan - Newser
What’s the profit margin of Bicara Therapeutics Inc.July 2025 Institutional & Long-Term Safe Return Strategies - خودرو بانک
Can Bicara Therapeutics Inc. rally from current levelsPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Sentiment analysis tools applied to Bicara Therapeutics Inc.Take Profit & Consistent Growth Equity Picks - Newser
Sell Signal: What’s the profit margin of Bicara Therapeutics Inc.July 2025 Selloffs & Stepwise Trade Execution Plans - خودرو بانک
How to escape a deep drawdown in Bicara Therapeutics Inc.Portfolio Gains Summary & Daily Chart Pattern Signals - Newser
Published on: 2025-09-03 09:02:39 - Newser
Published on: 2025-09-02 14:57:05 - Newser
Advanced analytics toolkit walkthrough for Bicara Therapeutics Inc.Trade Risk Summary & Daily Stock Trend Watchlist - Newser
Bicara Therapeutics Inc. stock volume spike explainedWeekly Trade Summary & Weekly High Return Forecasts - Newser
Does Bicara Therapeutics Inc. align with a passive investing strategyMarket Trend Report & Intraday High Probability Alerts - خودرو بانک
Is now a turning point for Bicara Therapeutics Inc.2025 Support & Resistance & Fast Gaining Stock Reports - Newser
How to use Fibonacci retracement on Bicara Therapeutics Inc.Quarterly Profit Report & Weekly High Conviction Ideas - Newser
Income Plays: What’s the profit margin of Bicara Therapeutics Inc.July 2025 News Drivers & Comprehensive Market Scan Reports - خودرو بانک
What’s next for Bicara Therapeutics Inc. stockTrade Analysis Summary & High Win Rate Trade Alerts - خودرو بانک
Institutional scanner results for Bicara Therapeutics Inc.Buy Signal & Weekly Stock Performance Updates - Newser
Is it time to cut losses on Bicara Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - Newser
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):